位置:首页 > 蛋白库 > PSD4_HUMAN
PSD4_HUMAN
ID   PSD4_HUMAN              Reviewed;        1056 AA.
AC   Q8NDX1; A6NEG7; A8K1Y0; O95621; Q4ZG34; Q6GPH8; Q8IYP4;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2006, sequence version 2.
DT   03-AUG-2022, entry version 152.
DE   RecName: Full=PH and SEC7 domain-containing protein 4;
DE   AltName: Full=Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 B;
DE            Short=Exchange factor for ARF6 B;
DE   AltName: Full=Pleckstrin homology and SEC7 domain-containing protein 4;
DE   AltName: Full=Telomeric of interleukin-1 cluster protein;
GN   Name=PSD4;
GN   Synonyms=EFA6B {ECO:0000303|PubMed:12082148, ECO:0000303|PubMed:23603394},
GN   TIC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=12082148; DOI=10.1242/jcs.115.14.2867;
RA   Derrien V., Couillault C., Franco M., Martineau S., Montcourrier P.,
RA   Houlgatte R., Chavrier P.;
RT   "A conserved carboxy-terminal domain of EFA6-family ARF6-guanine nucleotide
RT   exchange factors induces lengthening of microvilli-like membrane
RT   protrusions.";
RL   J. Cell Sci. 115:2867-2879(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Klenka T.P., Herbst R., Nicklin M.J.H.;
RT   "A novel human gene (TIC) telomeric of interleukin-1 cluster on chromosome
RT   2q13, homologous to the S.cerevisiae gene SEC 7.";
RL   Submitted (JUL-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-269.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (MAR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ALA-269.
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ALA-269.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   ALA-269.
RC   TISSUE=Leukocyte, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-491, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH VARIOUS PHOSPHATIDYLINOSITOL PHOSPHATE
RP   SPECIES.
RX   PubMed=21458045; DOI=10.1016/j.cell.2011.03.023;
RA   Paul P., van den Hoorn T., Jongsma M.L., Bakker M.J., Hengeveld R.,
RA   Janssen L., Cresswell P., Egan D.A., van Ham M., Ten Brinke A., Ovaa H.,
RA   Beijersbergen R.L., Kuijl C., Neefjes J.;
RT   "A Genome-wide multidimensional RNAi screen reveals pathways controlling
RT   MHC class II antigen presentation.";
RL   Cell 145:268-283(2011).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=23603394; DOI=10.1016/j.febslet.2013.03.042;
RA   Ueda T., Hanai A., Takei T., Kubo K., Ohgi M., Sakagami H., Takahashi S.,
RA   Shin H.W., Nakayama K.;
RT   "EFA6 activates Arf6 and participates in its targeting to the Flemming body
RT   during cytokinesis.";
RL   FEBS Lett. 587:1617-1623(2013).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131; SER-134; SER-143;
RP   SER-413 AND SER-1019, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-448, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Guanine nucleotide exchange factor for ARF6 and ARL14/ARF7.
CC       Through ARL14 activation, controls the movement of MHC class II-
CC       containing vesicles along the actin cytoskeleton in dendritic cells.
CC       Involved in membrane recycling. Interacts with several
CC       phosphatidylinositol phosphate species, including phosphatidylinositol
CC       3,4-bisphosphate, phosphatidylinositol 3,5-bisphosphate and
CC       phosphatidylinositol 4,5-bisphosphate. {ECO:0000269|PubMed:12082148,
CC       ECO:0000269|PubMed:21458045}.
CC   -!- INTERACTION:
CC       Q8NDX1-2; Q5SW96: LDLRAP1; NbExp=6; IntAct=EBI-12215623, EBI-747813;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12082148,
CC       ECO:0000269|PubMed:23603394}. Cell projection, ruffle membrane
CC       {ECO:0000269|PubMed:12082148, ECO:0000269|PubMed:23603394}. Note=In
CC       interphase associated with the plasma membrane, in particular with
CC       membrane ruffling regions (PubMed:23603394). Accumulates in dynamic
CC       actin-rich membrane ruffles and microvilli-like structures
CC       (PubMed:12082148). Recruited to membranes via phosphatidylinositol
CC       phosphate-binding (Probable). {ECO:0000269|PubMed:12082148,
CC       ECO:0000269|PubMed:23603394, ECO:0000305|PubMed:12082148}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8NDX1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NDX1-2; Sequence=VSP_020772, VSP_020773;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highest levels of expression are
CC       found in placenta, pancreas, spleen, thymus and peripheral blood.
CC       {ECO:0000269|PubMed:12082148}.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/psd4/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ459781; CAD30842.1; -; mRNA.
DR   EMBL; U63127; AAD00107.1; -; mRNA.
DR   EMBL; DQ452296; ABD96831.1; -; Genomic_DNA.
DR   EMBL; AK290045; BAF82734.1; -; mRNA.
DR   EMBL; AC016683; AAX88879.1; -; Genomic_DNA.
DR   EMBL; CH471217; EAW73626.1; -; Genomic_DNA.
DR   EMBL; BC035307; AAH35307.1; -; mRNA.
DR   EMBL; BC073151; AAH73151.1; -; mRNA.
DR   CCDS; CCDS33276.1; -. [Q8NDX1-1]
DR   RefSeq; NP_036587.2; NM_012455.2. [Q8NDX1-1]
DR   RefSeq; XP_005263691.1; XM_005263634.2. [Q8NDX1-1]
DR   AlphaFoldDB; Q8NDX1; -.
DR   SMR; Q8NDX1; -.
DR   BioGRID; 117094; 17.
DR   IntAct; Q8NDX1; 5.
DR   STRING; 9606.ENSP00000245796; -.
DR   iPTMnet; Q8NDX1; -.
DR   PhosphoSitePlus; Q8NDX1; -.
DR   BioMuta; PSD4; -.
DR   DMDM; 115515975; -.
DR   EPD; Q8NDX1; -.
DR   jPOST; Q8NDX1; -.
DR   MassIVE; Q8NDX1; -.
DR   MaxQB; Q8NDX1; -.
DR   PaxDb; Q8NDX1; -.
DR   PeptideAtlas; Q8NDX1; -.
DR   PRIDE; Q8NDX1; -.
DR   ProteomicsDB; 73075; -. [Q8NDX1-1]
DR   ProteomicsDB; 73076; -. [Q8NDX1-2]
DR   Antibodypedia; 47549; 67 antibodies from 18 providers.
DR   DNASU; 23550; -.
DR   Ensembl; ENST00000245796.11; ENSP00000245796.6; ENSG00000125637.16. [Q8NDX1-1]
DR   Ensembl; ENST00000441564.7; ENSP00000413997.2; ENSG00000125637.16. [Q8NDX1-2]
DR   GeneID; 23550; -.
DR   KEGG; hsa:23550; -.
DR   MANE-Select; ENST00000245796.11; ENSP00000245796.6; NM_012455.3; NP_036587.2.
DR   UCSC; uc002tjc.4; human. [Q8NDX1-1]
DR   CTD; 23550; -.
DR   DisGeNET; 23550; -.
DR   GeneCards; PSD4; -.
DR   HGNC; HGNC:19096; PSD4.
DR   HPA; ENSG00000125637; Tissue enhanced (lymphoid).
DR   MIM; 614442; gene.
DR   neXtProt; NX_Q8NDX1; -.
DR   OpenTargets; ENSG00000125637; -.
DR   PharmGKB; PA134875981; -.
DR   VEuPathDB; HostDB:ENSG00000125637; -.
DR   eggNOG; KOG0932; Eukaryota.
DR   GeneTree; ENSGT00940000161976; -.
DR   HOGENOM; CLU_011021_2_0_1; -.
DR   InParanoid; Q8NDX1; -.
DR   OMA; SAQGEHR; -.
DR   OrthoDB; 301851at2759; -.
DR   PhylomeDB; Q8NDX1; -.
DR   TreeFam; TF319755; -.
DR   PathwayCommons; Q8NDX1; -.
DR   SignaLink; Q8NDX1; -.
DR   BioGRID-ORCS; 23550; 210 hits in 1078 CRISPR screens.
DR   ChiTaRS; PSD4; human.
DR   GenomeRNAi; 23550; -.
DR   Pharos; Q8NDX1; Tbio.
DR   PRO; PR:Q8NDX1; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q8NDX1; protein.
DR   Bgee; ENSG00000125637; Expressed in granulocyte and 143 other tissues.
DR   ExpressionAtlas; Q8NDX1; baseline and differential.
DR   Genevisible; Q8NDX1; HS.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; IDA:UniProtKB.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0005543; F:phospholipid binding; IEA:InterPro.
DR   GO; GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro.
DR   CDD; cd00171; Sec7; 1.
DR   Gene3D; 1.10.1000.11; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR041681; PH_9.
DR   InterPro; IPR001605; PH_dom-spectrin-type.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR023394; Sec7_C_sf.
DR   InterPro; IPR000904; Sec7_dom.
DR   InterPro; IPR035999; Sec7_dom_sf.
DR   Pfam; PF15410; PH_9; 1.
DR   Pfam; PF01369; Sec7; 1.
DR   PRINTS; PR00683; SPECTRINPH.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00222; Sec7; 1.
DR   SUPFAM; SSF48425; SSF48425; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50190; SEC7; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cell projection; Coiled coil;
KW   Guanine-nucleotide releasing factor; Lipid-binding; Membrane;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN           1..1056
FT                   /note="PH and SEC7 domain-containing protein 4"
FT                   /id="PRO_0000251731"
FT   DOMAIN          544..736
FT                   /note="SEC7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00189"
FT   DOMAIN          776..892
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   REGION          25..71
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          87..149
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          195..239
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          340..362
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          388..533
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          546..581
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1004..1056
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          921..976
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        28..46
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        120..149
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        458..498
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        499..524
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        546..565
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1029..1045
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         131
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         134
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         143
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         413
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         448
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         469
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BLR5"
FT   MOD_RES         491
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         1019
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1022
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BLR5"
FT   VAR_SEQ         417..444
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_020772"
FT   VAR_SEQ         820
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_020773"
FT   VARIANT         83
FT                   /note="G -> R (in dbSNP:rs1562277)"
FT                   /id="VAR_051921"
FT   VARIANT         233
FT                   /note="S -> P (in dbSNP:rs12472091)"
FT                   /id="VAR_051922"
FT   VARIANT         269
FT                   /note="G -> A (in dbSNP:rs4849167)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|Ref.3,
FT                   ECO:0000269|Ref.6"
FT                   /id="VAR_027712"
FT   VARIANT         637
FT                   /note="R -> Q (in dbSNP:rs45487591)"
FT                   /id="VAR_051923"
FT   VARIANT         658
FT                   /note="I -> V (in dbSNP:rs45574835)"
FT                   /id="VAR_051924"
FT   CONFLICT        7
FT                   /note="L -> F (in Ref. 1; CAD30842 and 2; AAD00107)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        8
FT                   /note="P -> L (in Ref. 2; AAD00107)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        124
FT                   /note="E -> D (in Ref. 7; AAH35307)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        410
FT                   /note="T -> I (in Ref. 2; AAD00107)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        428
FT                   /note="L -> F (in Ref. 2; AAD00107)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1056 AA;  116249 MW;  C1FC0F22DB596116 CRC64;
     MMGDYRLPDH PQPMEILNLY LGDSLEPHPG ECPRETCSHE DPPEPFEEQT WATDPPEPTR
     QNVPPWGSGV ELTHLGSWVH QDGLEPCQEQ TRATDPPEST RQDAPPWGSG VELTHLGSPS
     AQREHRQNTA SPGSPVNSHL PGSPKQNRST STQVVFWAGI LQAQMCVLDL EEELEKTEGL
     KAGLKCCLPT PPVDLPGDTG LHSSPPENED SGEDSSEPEG EGQAWLREGT PDSSPQWGAE
     EESMFFSNPL FLASPCSENS ASGECFSWGA SDSHAGVRTG PESPATLEPP LPEDTVLWEL
     ESEPDLGDGA AISGHCTPPF PVPIYKPHSI CWASVAAAEG APAAPPGHGE SEGDRLGPAP
     SAAPCVDEAL TWESGCVGSD LGPAAHPVQP WASLSPEGWQ RGGPFWPQVT LNSQDRDERE
     GGHPQESLPC TLAPCPWRSP ASSPEPSSPE SESRGPGPRP SPASSQEGSP QLQHHSSGIL
     PKWTLDASQS SLLETDGEQP SSLKKKEAGE APKPGEEVKS EGTARPAETG DVQPDIHLTS
     AEHENLRTPM NSSWLPGSPM PQAQSPEEGQ RPPAGDKLAN GVRNNKVAWN LASRLYRLEG
     FRKSEVAAYL QKNNDFSRAV AEEYLSFFQF GGQSLDRALR SFLQALVLSG ETQERERILY
     QFSRRFHHCN PGIFPSVDSV HTLTCAIMLL NTDLHGQNIG KSMSCQEFIT NLNGLRDGGN
     FPKELLKALY WSIRSEKLEW AVDEEDTARP EKAQPSLPAG KMSKPFLQLA QDPTVPTYKQ
     GILARKMHQD ADGKKTPWGK RGWKMFHTLL RGMVLYFLKQ GEDHCLEGES LVGQMVDEPV
     GVHHSLATPA THYTKKPHVF QLRTADWRLY LFQAPTAKEM SSWIARINLA AATHSAPPFP
     AAVGSQRRFV RPILPVGPAQ SSLEEQHRSH ENCLDAAADD LLDLQRNLPE RRGRGRELEE
     HRLRKEYLEY EKTRYETYVQ LLVARLHCPS DALDLWEEQL GREAGGTREP KLSLKKSHSS
     PSLHQDEAPT TAKVKRNISE RRTYRKIIPK RNRNQL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024